Navigation Links
Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
Date:3/31/2008

- ACCOMPLISH first study to compare two single-pill combinations of commonly used high blood pressure medicines in reduction of cardiovascular

events

- RAS inhibition with an ACEI was the foundation of the combination therapies in this study and exceptional blood pressure control rates were

achieved

- Further analyses of full data set will examine effects on specific

patient populations - High dose formulations of benazepril/amlodipine besylate used in this

study are only available as Lotrel 5/40 mg and 10/40 mg capsule

CHICAGO, March 31 /PRNewswire/ -- Interim results from the ACCOMPLISH (Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension) trial demonstrate that high-risk, high blood pressure patients treated with Lotrel(R) (amlodipine besylate and benazepril HCl) had 20% fewer cardiovascular events than those taking a benazepril and hydrochlorothiazide (HCTZ) combination. This is the first cardiovascular outcomes trial in a hypertensive population where all patients were randomized to receive a single-pill combination treatment at the onset of the trial as opposed to a step care regimen.

"These results suggest that the combination of the angiotensin-converting enzyme inhibitor (ACEI) and calcium channel blocker in Lotrel yielded better patient outcomes in high-risk hypertensive patients than the ACEI and HCTZ combination," explained Kenneth Jamerson, MD, professor of internal medicine at the University of Michigan Medical Center in Ann Arbor and lead investigator of the trial. "Further, a strategy of starting patients in the trial on a single-pill combination proved to be very efficient in significantly increasing blood pressure control rates."

Lotrel is approved for the treatment of high blood pressure. It should not be used before other medications have bee
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
2. ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
3. New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy
4. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
5. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
6. Pharmion and MethylGene Start Phase 2 Combination Clinical Trial With MGCD0103 and Vidaza(R) in Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
7. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
8. New Drug Combination is Able to Eradicate Breast Metastases in Mice
9. Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
10. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Stem Cell Transplantation
11. Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)...  CARsgen, a leader in the development of Chimeric ... variety of cancers, today announced the completion of a ... China -based healthcare private equity fund.   ... development of new therapeutics for liver, lung, stomach and ... Shanghai Renji Hospital, the company plans to initiate clinical ...
(Date:11/26/2014)... and NEW YORK and ... -- As the leading distributor of market intelligence, MarketResearch.com ... research report by IQ4I Research and Consultancy focusing on ... learn more about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 ... Active Pharmaceutical Ingredients Global Market – Forecast to 2020 ...
(Date:11/26/2014)... FRANCISCO , Nov. 25, 2014  goBalto, Inc., ... has been recognized as a winner of Red Herring,s ... a Global Top 100 North America award in 2013, ... international technology landscape. Red Herring,s Top 100 ... identifying promising new companies and entrepreneurs. Red Herring editors ...
Breaking Medicine Technology:CARsgen Completes Series A Financing 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3
... Medical ( http://www.realtimemedical.com ), a global leader in ... selected to feature its latest advancements in diagnostic ... at e-Health 2012, as part of the Innovation ... from May 27 to 30, 2012 at the ...
... 25, 2012  Marken announced today that it has opened ... manage customer service operations and offer local service to ... Marken currently operates in the country through its partners, ... of the country.  This new office has been created ...
Cached Medicine Technology:Real Time Medical to Feature Diagnostic Imaging Software @ Innovation Showcase at e-Health 2012 2Marken Opens Branch Office In Seoul, South Korea 2
(Date:11/27/2014)... Let the Black Friday sales begin at ... on top, filled with skincare goodies, will delight and please ... while quantities last - no coupon required. See ... available on Amazon at the same sales prices. Links to ... page for ease. , The company published a 2014 ...
(Date:11/27/2014)... Guerrero (PRWEB) November 27, 2014 ... time individuals allot to sleep has lessened, and ... and laptops, the quality of sleep has eroded. ... falls asleep on the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ... worker’s productivity index by an incalculable amount, leading ...
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. ... to acquire a second language, new research suggests. But anyone ... gain a brain boost, the small study finds. ... study co-author Ping Li, co-director of the Center for Brain, ... more interesting, Li said, that "the brain networks of the ...
(Date:11/27/2014)... The founders of VIM & VIGR, a company ... compression socks, are proud to announce the debut of their ... Pressure (TM) knitting technology that is designed to increase the ... to adding flair and style to a product that has ... eye of a writer at The New York Times ...
(Date:11/27/2014)... VogueQueen.com is making every effort to offer more affordable ... the premier online supplier of elegant special occasion dresses ... huge selection of sexy prom dresses today. In addition ... many beautiful styles in its product line. Click to ... , “VogueQueen.com hopes to provide a truly unique shopping ...
Breaking Medicine News(10 mins):Health News:Big Christmas Sales Begin Today at Sublime Beauty® for all Christmas Gift Selections and Skincare Sets 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2
... March 10 In observance of,National Problem Gambling ... Revenue today highlighted the availability of counseling,and treatment ... addiction., "Problem gambling impacts not only the ... Secretary Dr. Calvin Johnson. "The Commonwealth,of Pennsylvania is ...
... N.J., March 10 Medco Health,Solutions, Inc. (NYSE: ... in,March as follows:, On Monday, March 17, 2008, ... Health Group, Inc., Medco,s specialty pharmacy,subsidiary, is scheduled to ... The presentation at the Boston Marriott Copley,Place will begin ...
... programs do not provide coverage to international ... ... Corners, one of the,industry,s most experienced travel health insurance providers, alerts,parents ... travel abroad for spring break vacations. Most health insurance,programs do not ...
... for less radical procedures may not be getting them, study ... skills and preferences may dictate treatment choices for kidney cancer ... patient,s general health, a new study finds. , This ... procedures, such as a partial nephrectomy where only part of ...
... March 10 ZARS Pharma, Inc. announced,today ... Pharma S.A. the,exclusive promotion and distribution rights ... Canada for Pliaglis(TM) (lidocaine and tetracaine) Cream,7%/7%, ... safe local,anesthesia in patients undergoing potentially painful ...
... Over One ... Million, PHILADELPHIA, ... have a form of,lupus, the chronic (incurable) disease that can result in ... and other health effects, including organ failure and death.,Lupus mostly strikes women ...
Cached Medicine News:Health News:State Agencies Highlight Available Assistance During Problem Gambling Awareness Week 2Health News:Medco to Present at Cowen and Company and Lehman Brothers Health Care Conferences 2Health News:Seven Corners Alerts Spring Breakers that They Need Travel Insurance to Vacation Abroad 2Health News:Seven Corners Alerts Spring Breakers that They Need Travel Insurance to Vacation Abroad 3Health News:Surgeon's Preferences Dictate Choice of Kidney Cancer Surgery 2Health News:Surgeon's Preferences Dictate Choice of Kidney Cancer Surgery 3Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 3Health News:Lupus Foundation to Host Community Outreach Initiatives 2Health News:Lupus Foundation to Host Community Outreach Initiatives 3Health News:Lupus Foundation to Host Community Outreach Initiatives 4
Full automatic, ready-to-use strip washer....
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
MultiWash Advantage is a versatile microplate washer engineered for reliability. It is designed for lab environments to help streamline their daily processes....
... an unmatched combination of speed, accuracy and ... assessing and monitoring a patient's A1C levels., ... simple fingerstick and delivers A1C results in ... a proven and time-tested having received full ...
Medicine Products: